Office of Research on Women's Health

Scientific Workshop:
Menopausal Hormone Therapy
October 23-24, 2002

The workshop may be viewed at http://videocast.nih.gov (look under Past Events).

The purpose of this National Institutes of Health (NIH) conference was to review the results from the arm of the Women's Health Initiative (WHI) clinical trial studying combination estrogen and progestin that was recently stopped, to place them in the context of other completed and ongoing Federally funded research on menopausal combination hormone therapy (HT), and to help clinicians and patients understand the implications of current knowledge on decisions regarding short- and long-term use of HT. In addition, the most recent information from the U.S. Preventative Services Task Force on hormone therapy and chronic disease was presented as were recommendations on specific clinical uses of HT from other professional organizations. The conference provided information about alternatives for HT for treatment of specific conditions such as osteoporosis, heart disease, and vasomotor symptoms that include mood and sleep disorders. Other ongoing studies were reviewed.

Statement by Elias A. Zerhouni, M.D., Director, National Institutes of Health

To view a speaker's slide presentation (PowerPoint format) from the workshop, click on the name of the speaker below.

Final Agenda

Selected Articles Related to Menopausal Hormone Therapy (2000 - 2002)

Selected Articles Related to Menopausal Hormone Therapy (1981 - 1999)

Menopause Management and Hormone Therapy page

Annals of Internal Medicine

 

Valid XHTML 1.0!
Valid CSS!